Font Size:
a
A
A
Keyword [Structure-based]
Result: 81 - 100 | Page: 5 of 7
81.
Structure-based design and synthesis of small-molecules directed towards novel antimicrobial drug discovery
82.
Structure-based drug design: What to do when you don't have a structure
83.
Discovery of novel small molecule enzyme inhibitors and receptor modulators through structure-based computational design
84.
Design of Novel Inhibitors for Infectious Diseases using Structure-based Drug Design: Virtual Screening, Homology Modeling and Molecular Dynamics
85.
Structure based design of peptidomimetic inhibitors of the MLL1-WDR5 interaction
86.
Structure-based design of sickling inhibitors
87.
Use of modern structure-based drug design techniques in the discovery and development of novel antimicrobial candidates
88.
Structure-based design of novel inhibitors of plasmepsins: A family of anti-malarial targets
89.
Structure-based drug-design software tool
90.
Protein Flexibility In Structure-Based Drug Design
91.
Development of computational tools for structure-based drug design
92.
Informatics in drug discovery: Identifying transcription factor targets and structure-based drug screening
93.
Crystallographic, molecular dynamics, and enzymatic studies of multi-drug resistant HIV-1 protease and implications for structure based drug design (project 1); crystallographic studies of human myelin protein zero (project 2)
94.
Homology modeling of the smooth and skeletal myosin light chain kinase: Implications for structure based drug design and ligand specificity
95.
Integrating structure-based drug design and multivalency for creating effective antagonists of cholera toxin and Escherichia coli heat-labile enterotoxin
96.
Structure-based design and characterization of ricin and Shiga toxin inhibitors
97.
Computational methods for structure-based drug design and macromolecular crystallization
98.
Computational methods for structure-based and combinatorial drug design
99.
Cholera toxin and heat-labile enterotoxin: Structural studies of assembly and design of active A-subunit constructs
100.
Crystallographic studies of sialidase and structure-based design of inhibitors
<<First
<Prev
Next>
Last>>
Jump to